Skip To Main Content
Tbilisi Heart on Muck Rack

Tbilisi Heart

As seen in: Arthritis Research & Therapy
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Tbilisi

Contact Tbilisi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A phase 3, randomized, double-blind, active-controlled clinical trial to compare BAT1806/BIIB800, a tocilizumab biosimilar, with tocilizumab reference product in participants with moderate-to-severe rheumatoid arthritis with inadequate response to methotr

|
By Cm Umk, Nowa Sól, Tbilisi Heart
| Arthritis Research & Therapy Verified
This was a phase 3, multicenter, multiregional, randomized, double-blind, active-controlled clinical trial [5]. The study comprised a ≤ 28-day screening period, an initial 24-week period (TP1), and a subsequent 24-week period (TP2).
Open in Who Shared Issue with article?
See all 1 articles